期刊文献+

牛AsiaⅠ型口蹄疫病毒重组蛋白疫苗的构建及功能研究

Construction and functional study of recombinant vaccine for bovine AsiaⅠfoot-and-mouth disease virus
下载PDF
导出
摘要 目的为了取代有安全隐患的牛AsiaⅠ型口蹄疫病毒灭活疫苗,我们构建了基因工程重组蛋白疫苗。方法应用PCR方法合成含有表位的基因片段,经过克隆连接获得重组基因,在大肠杆菌中表达后经镍亲和层析纯化重组蛋白。重组蛋白免疫豚鼠后,分别经ELISA和乳鼠中和实验检测血清中抗FMDV抗体水平。结果构建了牛AsiaⅠ型口蹄疫病毒重组蛋白疫苗的结构基因,并成功表达和纯化了该重组蛋白。功能实验表明,该蛋白在豚鼠体内诱生了高水平的抗牛AsiaⅠ型口蹄疫病毒的中和性抗体。结论该重组蛋白为制备牛AsiaⅠ型口蹄疫病毒新型疫苗提供了有价值的线索。 In this study,we tried to develop a recombinant protein vaccine for preventing bovine Asia I foot-and-mouth disease virus infection.One B cell epitope and two T cell epitopes from FMDV Vp1 protein were chosen to construct genes encoding recombinant proteins RA2.And then RA2 gene(consisting BT2-BT2-BT1-BT2-BT2) was constructed by PCR and DNA cloning,which was subcloned into pET28a and highly expressed in BL21(DE3).RA2 protein was purified by nickel chromatography and immunized in genuine pigs. ELISA and suckling mice protection method found ligh level anti-FMDV antibody in sera of the immunized genuine pigs.The results imply that the recombinant bovine Asia I foot-and-mouth disease virus vaccine RA2 may be developed as a safe and effective novel vaccine.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第4期312-315,共4页 Immunological Journal
关键词 口蹄疫 免疫 重组蛋白疫苗 表位 原核表达 Foot-and-mouth disease Immunity Recombinant vaccine Epitope Prokaryotic expression
  • 相关文献

参考文献7

  • 1Knowles N J, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus [J]. Virus Res, 2003, 91 (1): 65 -80.
  • 2Doel TR. FMD vaccine[J]. Virus Res, 2003, 91: 81-99.
  • 3Francis M J, Hastings GZ, Brown F, et al. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus [J]. Immunology, 1991, 73(3): 249-54.
  • 4Volpina OM, Surovoy AY, Zhmak MN, et al. A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection[J]. Vaccine, 1999, 17(6): 577-84.
  • 5Logan DR, Abu Ghazaleh W, Blakemore S, et al. Structure of a major immunogenic site on foot-and-mouth disease virus [J]. Nature, 1993, 362 (6420): 566-568.
  • 6Elizabeth E, John W, Stephen C, et al. Structure of Foot-and-mouth disease virus serotype A106 alone and complexed with oligosaccharide receptor:, receptor conserva- tion in the face of antigenic variation [J]. J Gen Virol, 2005, 86 (Pt7): 1909-1920.
  • 7冉波,邵明玉,张培因,冯宇,卫红飞,王莉,王燕媚,胡大利,王丽颖,于永利.O型口蹄疫病毒VP1表位重组蛋白疫苗的构建、表达和纯化[J].免疫学杂志,2006,22(3):265-268. 被引量:15

二级参考文献14

  • 1龚团莲,孙立杰,毛景东,任菊秋,廉春艳.口蹄疫研究概述[J].内蒙古民族大学学报(自然科学版),2001,16(4):393-396. 被引量:20
  • 2Marvin J,Grubman MJ,Baxt B.Foot-and-mouth disease [J]. Clin Microbiol Rev, 2004, 17(2) :465 - 493.
  • 3Wild TF, Burroughs JN, Brown F. Surface structure of foot-and-mouth disease virus [ J ]. J Gen Virol, 1969, 4 (3) :313 - 320.
  • 4Volpina OM, Surovoy AY, Zhmak MN, et al. A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection [J]. Vaccine, 1999, 17(6):577-584.
  • 5Barnett PV, Pullen L, Staple RF, et al. A protective antipeptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence [J]. J Gen Virol, 1996, 77(5) : 1 011 -1 018.
  • 6Francis MJ, Hastings GZ, Brown F, et al. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus [J]. Immunology, 1991, 73(3):249-254.
  • 7Clarke BE, Newton SE, Carroll AR, et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein [J]. Nature, 1987, 330(6146) :381 - 384.
  • 8Winther MD, Allen G, Bomford RH, et al. Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals [J].J Immunol, 1986, 136(5):1 835- 1 840.
  • 9Rothel JS, Wood PR, Seow HF, et al. Urea/DTT solubilization of a recombinant Taenia ovis antigen, 45W, expressed asa GST fusion protein results in enhanced protective immune response to the 45W moiety [J]. Vaccine, 1997, 15(5):469 - 472.
  • 10Burroughs JN, Rowlands DJ, Sangar DV, et al. Further evidence for multiple proteins in the foot-and-mouth disease virus particle [J]. J Gen Virol, 1971, 13(1):73-84.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部